The private equity firms are in the final stages of talks and could announce an agreement within days. The proposed offer is said to exceed $75 per share. Hologic's stock surged 6% in after-hours trading following the news, closing at $69.85 on Friday for a market capitalisation of about $15.5bn. Headquartered in Marlborough, Massachusetts, Hologic develops diagnostic and imaging systems focused on women's health, including screening tools for breast and cervical cancer and testing solutions for infectious diseases such as Covid-19. Subscribe to our Newsletter to increase your edge. Don't worry about the news anymore, through our newsletter you'll receive weekly access to what is happening. Join 120,000 other PE professionals today.
learn more
